Who owns ROCKET PHARMACEUTICALS, INC. (RCKT)? Elite investor 13F holders
4 tracked elite investors reported holding ROCKET PHARMACEUTICALS, INC as of 2026-06-30, including Maverick Capital, D.E. Shaw, Renaissance Technologies LLC, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
4 tracked investors currently reported holding · Latest report period: 2026-06-30
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Maverick Capital | ROCKET PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 13419953.00 USD | 3923963.000000 | Shares | add | Original filing |
| D.E. Shaw | ROCKET PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3250888.00 USD | 950552.000000 | Shares | reduce | Original filing |
| Renaissance Technologies LLC | ROCKET PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 2711971.00 USD | 792974.000000 | Shares | add | Original filing |
| Tudor Investment | ROCKET PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 172686.00 USD | 50493.000000 | Shares | hold | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.